58.8 F
New York
Tuesday, October 20, 2020

VYNE Therapeutics Inc. (NASDAQ:VYNE) is Holding Steady

Must read

The Unprecedented Rise of The Kraft Heinz Company (NASDAQ:KHC)

The Kraft Heinz Company (KHC) shares are trading at lower $32.16 and the avg recommendation for the stock is Moderate Buy, while the current...

Johnson Controls International plc (NYSE:JCI) is Holding Steady

Johnson Controls International plc (JCI) shares are trading at higher $43.02 and the avg recommendation for the stock is Moderate Buy, while the current...

The Forecast Just Changed on DPW Holdings Inc. (AMEX:DPW)

DPW Holdings Inc. (DPW) shares are trading at lower $2.19. To add more color to this target, the company’s high over the last year...

CBL & Associates Properties Inc. (NYSE:CBL) Recent Earnings Shows Major Concern

CBL & Associates Properties Inc. (CBL) shares are trading at lower $0.16 and the avg recommendation for the stock is Moderate Sell. To add...

VYNE Therapeutics Inc. (VYNE) shares are trading at higher $1.62 and the avg recommendation for the stock is Strong Buy.

To add more color to this target, the company’s high over the last year is $7.48 and the low is $1.00. Over the last 52 weeks, VYNE is down -65.53% while the S&P 500 is up 8.70%. The catalyst for this interesting swing was the company’s recent earnings report.

A Notable Earnings Report

In the last quarter, VYNE reported a profit of $11.47 million. VYNE Therapeutics Inc. also saw revenues increase to $11.69 million. In addition, VYNE has free cash flow of -$88.18 million as of 06-2020. The company’s EBITDA came in at -$112.74 million which compares well with its peers.

VYNE Return on Equity (ROE) is -400.60%, and its Return on Assets is -209.80%. All told, it is clear that, VYNE needs to be on your watchlist.

Find out when VYNE reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. VYNE has a short ratio of 3.38 and outstanding shares of 138.65M.

Company Outlook

VYNE has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 3.0 million and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at -3.75. VYNE Therapeutics Inc. VYNE also noted assets of $130.84 million at the end of the last quarter. Investors should also keep an eye on sector updates as VYNE has historically followed its peers on positive news.

All told, VYNE Therapeutics Inc. VYNE has strung together solid data and demonstrated underlying fundamentals. At its current valuation, VYNE represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.

VYNE Therapeutics Inc. VYNE is now commanding a market cap of 268.68M and a float of 138.08M. VYNE is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of VYNE stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in VYNE, either long or short, and we have not been compensated for this article.

Latest article

Vystar Corp. (OTCMKTS:VYST) Remarkable Run Hits a Bump

Vystar Corp. (OTCMKTS:VYST) stock has been on a remarkable run in recent weeks, but VYST saw some profit taking on on Monday....

Northwest Biotherapeutics Inc (OTCMKTS:NWBO) Bullish Trend Worth a Closer Look

Over the course of the past week, Northwest Biotherapeutics, Inc (OTCMKTS:NWBO) stock has gone on a remarkable rally and over the period,...

Is Now the Time to Invest in Kansas City Southern (NYSE:KSU)?

Kansas City Southern (KSU) shares are trading at lower $179.01 and the avg recommendation for the stock is Moderate Buy, while the current analyst...

So-Young International Inc. (NASDAQ:SY) Stock is Soaring, Here is Why

So-Young International Inc. (SY) shares are trading at higher $12.94 and the avg recommendation for the stock is Strong Buy, while the current analyst...

Consolidated Edison Inc. (NYSE:ED) is Holding Steady

Consolidated Edison Inc. (ED) shares are trading at lower $81.70 and the avg recommendation for the stock is Hold, while the current analyst price...